Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Notice of Proposed Sale · 144

OrthoPediatrics Corp.

KIDSNASDAQEQUITYCurrent

Notice of Proposed Sale

Filed Aug 24, 2026Accepted Aug 24, 2026, 4:33 PM EDTFiling CIK 1719228Accession 0001425450-26-000079
Share

Structured filing — 144

primary_doc.xml

Open full document ↗

Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.

Proposed-sale notice

Issuer
Orthopediatrics Corp.
Issuer CIK
0001425450
Phone
5742686379
Person for whose account securities are to be sold
Squadron Capital, LLC
Relationships to issuer
10% Stockholder
Street
2850 Frontier Drive
City
Warsaw
State / country code
IN
Postal code
46582

Securities proposed for sale

Securities proposed for sale · 1 reported row
SecurityProposed unitsAggregate market valueUnits outstandingApproximate sale dateExchangeBroker / market maker
Common Stock700,00018,361,00026,109,78808/24/2026NASDAQStifel Nicolaus & Company Inc

Broker / market maker — proposed row 1, entry 1

Name
Stifel Nicolaus & Company Inc
Street
501 N Broadway
City
St. Louis
State / country code
MO
Postal code
63102

Acquisition of securities to be sold

Acquisition of securities to be sold · 1 reported row
SecurityAcquiredNature of acquisitionAcquired fromAmount acquiredGift transactionPayment dateNature of payment
Common Stock09/20/2022Purchase of Common sharesIssuer1,525,000N08/15/2022Cash plus forgiveness of debt

Prior-sale reporting

Nothing to report for the preceding three months
Y

Remarks

The number of shares to be sold by the Reporting Person represents approximately 10% of its holdings of the Issuers outstanding common stock. The proposed sale is being undertaken to provide additional capital for the Reporting Persons other portfolio businesses.

Notice signature

Notice date
08/24/2026
Signed
David Pelizzon, President

Company context

Current securities

Recent company filings

  1. 10-Q filingOct 28, 2026
  2. Regulation FD DisclosureOct 27, 2026
  3. Results of Operations and Financial ConditionOct 27, 2026
  4. 4 filingSep 1, 2026
  5. 10-Q filingAug 5, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.